Skip to main content
AIDS (London, England)
The independent effect of drug resistance on T cell activation in HIV infection.
Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy.
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia.
Impact of intrapeptide epitope location on CD8 T cell recognition: implications for design of overlapping peptide panels.
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.
A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study.
Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.
Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone.
Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.
